American International Group’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-25,031
Closed -$71.1K 144
2024
Q1
$71.1K Sell
25,031
-215
-0.9% -$611 ﹤0.01% 2681
2023
Q4
$372K Sell
25,246
-102
-0.4% -$1.5K ﹤0.01% 1827
2023
Q3
$464K Buy
25,348
+901
+4% +$16.5K ﹤0.01% 1649
2023
Q2
$527K Buy
24,447
+109
+0.4% +$2.35K ﹤0.01% 1607
2023
Q1
$714K Buy
24,338
+485
+2% +$14.2K ﹤0.01% 1412
2022
Q4
$881K Buy
23,853
+7,117
+43% +$263K 0.01% 1269
2022
Q3
$471K Buy
16,736
+11,368
+212% +$320K ﹤0.01% 1617
2022
Q2
$103K Buy
5,368
+608
+13% +$11.7K ﹤0.01% 2583
2022
Q1
$61K Buy
+4,760
New +$61K ﹤0.01% 2773